About DNA Sequencing Instruments
DNA sequencing could be a technology within which many DNA strands can be sequenced through large parallelization. This sequencing includes each Sanger’s technique of sequencing and non-Sanger’s methods of sequencing. advantages like low value, high accuracy & speed, and precise results even from low sample input are offered by DNA sequencing over microarray and other genomic analysis methods. DNA sequencing is employed to execute numerous applications like biomarker discovery, oncology studies, personalized drugs, forensics, and others. it's streamlined nucleotide analysis and consists of wide replaced conventional tools of genetic science, particularly microarray, genotyping, and others. The demand for DNA sequencing has increased considerably, as a result of a surge in sequencing applications and an increase in technological advancements in DNA sequencing. additionally, a surge in the number of genome mapping programs globally and a rise in R&D investment drive the market growth.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The demand for DNA sequencing has increased significantly, owing to a surge in sequencing applications and a rise in technological advancements in DNA sequencing. In addition, a surge in the number of genome mapping programs globally and an increase in R&D investment drive the market growth. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global DNA Sequencing Instruments market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Abbott Laboratories (United States), Agilent Technologies, Inc, Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd (Switzerland), Illumina, Inc. (United States), LI-COR Biosciences, Inc (United States), Pacific Biosciences of California, Inc (United States) and SIEMENS AG (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are PerkinElmer Inc (United States), Thermo Fisher Scientific, Inc. (United States) and Others.
Segmentation Overview
AMA Research has segmented the market of Global DNA Sequencing Instruments market by Type (Consumable, Instrument and Service), Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics and Others) and Region.
On the basis of geography, the market of DNA Sequencing Instruments has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Sequencing by Synthesis will boost the DNA Sequencing Instruments market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-Users, the sub-segment i.e. Academic & Government Research Institutes will boost the DNA Sequencing Instruments market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Need For Precise Results Even from Low Sample Input
Market Growth Drivers:
Surge In Number of Genome Mapping Programs and Increase In Applications of The Instruments
Challenges:
Intense Competition in The Market
Restraints:
High Cost of The Instrument
Opportunities:
Rise In Technological Advancements in DNA Sequencing and Increase In R&D Investment
Market Leaders and their expansionary development strategies
In April 2022, Thermo Fisher Scientific launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that delivers results in one day.
In October 2021, Research labs performing Sanger sequencing can now use Promega chemistry on any capillary electrophoresis (CE) platform. The ProDye™ Terminator Sequencing System, launched today by Promega Corporation, can be implemented on any CE instrument, including the benchtop Spectrum Compact CE System.
Key Target Audience
Manufacturers of DNA Sequencing Instruments, Suppliers and distributors of DNA Sequencing Instruments, Governmental and Regulatory bodies and End-Users
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.